Covid-19: Remdesivir is helpful but not a wonder drug, say researchers

Antiviral drug remdesivir helps patients hospitalised with covid-19 recover faster and may also reduce mortality, according to the US National Institutes of Health (NIH). The drug—developed by US pharmaceutical company Gilead—is being tested through a randomised, controlled trial involving 1063 patients from several countries including the US, UK, and Singapore. The study began in February. Currently, no official results have been published,...